Saturday, July 4, 2020

AstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients

AstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients The company has received import and market permission from DCGI in Form CT-20 (Marketing Authorisation- Additional Indication).

from Moneycontrol Business News https://ift.tt/2ZAr8KR

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...